Health Economics and Policy

Ophthalmology is now ready to embrace gene therapy technologies that promise a stream of novel products for unmet medical needs

How does a novel portable head-mounted perimeter compare with the gold standard in visual field testing?

In an era of improved technologies, it has never been easier – or more affordable – to identify undiagnosed glaucoma patients

An art-based investigation into why people won't donate their corneas after death

The ForeseeHome® AMD Monitoring Program provides a safety net for intermediate AMD patients from the comfort of home, especially if routine eye exams

What role has Orbis' flagship telemedicine platform Cybersight played in the COVID-19 pandemic?

Tackling rapid acceleration of progressive childhood myopia following a period of increased screen use and reduced outdoor activity

The technologies and treatments set to revolutionize the way we approach ocular surface disease

How will the pandemic affect sight-saving research in the long term?

The latest industry news – in 50 words or less